|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,617.00 JPY | -1.23% |
|
-3.05% | +16.17% |
| Mar. 05 | Takeda Pharmaceutical to Cut 400 US Jobs, Invest in Blood Products | MT |
| Mar. 04 | Takeda to Reduce US Workforce in Priorities Overhaul Ahead of CEO Change | MT |
| Capitalization | 8,984B 57B 49.14B 44.36B 42.57B 77.62B 5,238B 81.23B 524B 210B 2,512B 214B 209B | P/E ratio 2026 * |
51.3x | P/E ratio 2027 * | 30.9x |
|---|---|---|---|---|---|
| Enterprise value | 12,910B 81.91B 70.62B 63.75B 61.17B 112B 7,527B 117B 754B 302B 3,610B 307B 301B | EV / Sales 2026 * |
2.85x | EV / Sales 2027 * | 2.76x |
| Free-Float |
99.61% | Yield 2026 * |
3.52% | Yield 2027 * | 3.58% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -1.23% | ||
| 1 week | -3.05% | ||
| Current month | -3.47% | ||
| 1 month | +2.05% | ||
| 3 months | +24.96% | ||
| 6 months | +24.46% | ||
| Current year | +16.17% |
| 1 week | 5,509 |  | 5,790 |
| 1 month | 5,509 | | 5,848 |
| Current year | 4,863 | | 5,848 |
| 1 year | 3,916 | | 5,848 |
| 3 years | 3,852 | | 5,848 |
| 5 years | 2,993 | | 5,848 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 59 | 2015-03-31 |
Milano Furuta
DFI | Director of Finance/CFO | - | 2024-03-31 |
Mwana Lugogo
CMP | Compliance Officer | 56 | 2011-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Weber
BRD | Director/Board Member | 59 | 2014-05-31 |
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
| Director/Board Member | 73 | 2016-05-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +7.12% | 24.44% | 29 M€ | |
| +8.92% | 5% | 476 M€ | |
| +7.24% | 3.8% | 2,604 M€ | |
| +3.59% | 3.26% | 96 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.23% | -3.05% | +26.22% | +27.57% | 57B | |
| +0.40% | -2.64% | +19.45% | +212.80% | 885B | |
| +0.38% | -3.06% | +43.68% | +59.32% | 579B | |
| -2.75% | -4.07% | +3.72% | +52.51% | 407B | |
| -3.09% | -9.01% | +7.42% | +25.03% | 350B | |
| +1.35% | -4.14% | +22.88% | +64.98% | 302B | |
| -1.12% | -6.28% | +20.71% | +31.55% | 301B | |
| -0.41% | -5.40% | +20.60% | +6.74% | 286B | |
| -0.15% | -4.75% | +12.22% | +62.70% | 199B | |
| +0.39% | -3.78% | +23.17% | +82.86% | 179B | |
| Average | -0.68% | -4.62% | +20.01% | +62.61% | 354.57B | |
| Weighted average by Cap. | -0.50% | -4.82% | +20.80% | +88.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4,529B 28.73B 24.77B 22.36B 21.46B 39.13B 2,641B 40.95B 264B 106B 1,266B 108B 106B | 4,572B 29.01B 25.01B 22.58B 21.66B 39.5B 2,666B 41.34B 267B 107B 1,278B 109B 107B |
| Net income | 172B 1.09B 939M 848M 814M 1.48B 100B 1.55B 10.03B 4.02B 48.02B 4.09B 4B | 287B 1.82B 1.57B 1.42B 1.36B 2.48B 167B 2.6B 16.77B 6.72B 80.3B 6.84B 6.69B |
| Net Debt | 3,926B 24.91B 21.48B 19.39B 18.6B 33.92B 2,289B 35.5B 229B 91.82B 1,098B 93.49B 91.49B | 3,642B 23.11B 19.92B 17.98B 17.26B 31.47B 2,123B 32.93B 213B 85.17B 1,018B 86.72B 84.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-09 | 5,617.00 ¥ | -1.23% | 5,182,700 |
| 26-03-06 | 5,687.00 ¥ | +0.99% | 4,179,700 |
| 26-03-05 | 5,631.00 ¥ | +0.41% | 4,650,300 |
| 26-03-04 | 5,608.00 ¥ | -2.08% | 5,848,200 |
| 26-03-03 | 5,727.00 ¥ | -1.16% | 4,834,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
